GlaxoSmithKline Pakistan Limited
GlaxoSmithKline Pakistan Limited, commonly referred to as GSK Pakistan, is a leading healthcare company headquartered in Karachi, Pakistan. Established in 1947, GSK Pakistan has made significant strides in the pharmaceutical and consumer healthcare sectors, focusing on innovative medicines, vaccines, and consumer health products. With a strong presence across major regions in Pakistan, GSK Pakistan is renowned for its commitment to improving health outcomes through its diverse portfolio, which includes prescription medications, over-the-counter products, and vaccines. The company is particularly noted for its advancements in respiratory and infectious disease treatments. As a subsidiary of GlaxoSmithKline plc, GSK Pakistan has achieved notable market recognition, consistently ranking among the top pharmaceutical companies in the country, driven by its dedication to research and development and a robust distribution network.
DitchCarbon Score
How does GlaxoSmithKline Pakistan Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
GlaxoSmithKline Pakistan Limited's score of 54 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
GlaxoSmithKline Pakistan Limited's reported carbon emissions
GlaxoSmithKline Pakistan Limited, headquartered in PK, currently does not have publicly available carbon emissions data for the most recent year. As a result, specific figures regarding their Scope 1, 2, or 3 emissions are not provided. While there are no documented reduction targets or climate pledges available, it is essential to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and reducing their carbon footprints. GSK Pakistan may be engaging in similar initiatives, although specific details are not disclosed. In the absence of concrete emissions data and reduction commitments, it is crucial for stakeholders to monitor GSK Pakistan's future sustainability reports for updates on their climate strategies and performance.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
GlaxoSmithKline Pakistan Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
